Latest news with #SweetSpot
Yahoo
3 days ago
- Entertainment
- Yahoo
Watch Justin Bieber Have a ‘Sweet Spot' Dance Party With Sexyy Red in New Video
Justin Bieber and Sexyy Red are getting their swag on. In a video shared by both artists on Instagram on Friday (July 11) — the same day the Canadian pop star dropped his new album, SWAG, with barely any notice — the duo dance along to their new collaboration 'Sweet Spot.' As the rapper twerks and lip-syncs to her verse, Bieber kisses her on the temple before joining her in grooving to the track. More from Billboard Justin Bieber's 'Swag': All 21 Tracks Ranked Oasis Storm Back to U.K. No. 1 Following Reunion Tour Boost Kid Cudi Marries Longtime Partner Lola Abecassis Sartore: 'Next We Need This Baby' 'love you frienddddddddddddd,' the singer captioned his post, noting that he was 'faded' in the smoke-filled clip. In her caption, Sexyy wrote, 'Congratulations my friend just dropped his album.' The hip-hop star is one of a few collaborators Bieber worked with on SWAG, which also features guest spots from Gunna, Druski and Cash Cobain. The LP had barely any promotion leading up to its midnight release, with Bieber simply posting photos of billboards displaying the track list in different cities on Instagram hours before it dropped. SWAG marks Bieber's first album in four years, following 2021's Justice, which spent two weeks at No. 1 on the Billboard 200. Before the new record arrived, fans couldn't be sure if or when he would ever release music again, as Bieber had appeared to take a large step back from his pop star career in recent years to focus on his family with Hailey Bieber — with whom he shares 11-month-old son Jack Blues — and recover from partial facial paralysis caused by Ramsay Hunt Syndrome. Sexyy's appearance on SWAG follows her April single 'Hoochie Coochie.' She's also teamed up with Tommy Richman, Snoop Dogg and Central Cee on various tracks in 2025. Watch Bieber and Sexyy turn up to their new collaboration below. Best of Billboard Chart Rewind: In 1989, New Kids on the Block Were 'Hangin' Tough' at No. 1 Janet Jackson's Biggest Billboard Hot 100 Hits H.E.R. & Chris Brown 'Come Through' to No. 1 on Adult R&B Airplay Chart
Elle
3 days ago
- Entertainment
- Elle
Hailey Bieber Shares Intimate New Pic of Justin Bieber and Jack Blues at Home
THE RUNDOWN On Saturday, Hailey Bieber shared a new carousel of images on Instagram from her recent life, including an intimate new shot of husband Justin Bieber with their infant son, Jack Blues. In the photo of Justin and Jack, the father and son duo are wrapped up in towels and laying down together. Justin is shirtless and showing off his tattoos, wearing a blue and white tropical print bathing suit. Jack Blues is wearing a blue shirt with the word 'Mardi' embroidered on it, which means 'Tuesday' in French. Justin has his hand wrapped around one of Jack's ankles, the other twined underneath him. In her Stories, the Rhode founder continued to share support for her husband, posting links to his new album and clips from several songs, including 'Daisies' and 'Sweet Spot' with Sexxy Red. In the lyrics to 'Daisies,' Justin seems to be hinting how he and Hailey work through conflict. In the first verse and chorus, he sings, 'You leave me on read, babe, but I still get the message / Instead of a line, it's three dots, but I can connect them / And if it ain't right, babe, you know I respect it / But if you need time, just take your time / Honey, I get it, I get it, I get it / Way you got me all in my head / Think I'd rather you in my bed / Whatever it is, you know I can take it / I'm countin' the days, how many days 'til I can see you again?' On June 24, a source told Us Weekly that the couple was going through a 'difficult time,' but that Hailey and Justin would 'do anything to make it [their marriage] work.' 'They believe they are soulmates and meant for each other,' the source added.
Daily Mail
5 days ago
- Entertainment
- Daily Mail
Justin Bieber slammed for shocking intimate act with Sexyy Red to plug new album Swag: 'This is embarrassing!'
Justin Bieber was blasted by fans for sharing yet another cozy video with rapper Sexyy Red to plug his new music. The Baby hitmaker, 31, who shares a son with wife Hailey Bieber, filmed himself 'faded' (drunk or stoned) dancing with the musician, before wrapping an arm around her and planting a kiss on her head. The duo - who have collaborated on raunchy track Sweet Spot - were seen dancing to their track in the video while clouds of apparent cigarette smoke blew over their faces. The video was captioned: 'love you friendddd, faded in this video don't judge' - with Hailey hitting the like button. However fans were left furious at the 'embarrassing' clip from the married star, just months after he came under fire for kissing the rapper at her single launch party in April. One wrote: 'Won't judge you for being faded but I WILL judge you for behaving this way with a woman who isn't your wife 1. The song lyrics 2. The forehead kiss 3. The touching 4. Saying I love you in the caption. 'Being someone who is married.... let's not do this with other women. You made a vow to her. Appreciate and love her 'I'm a Belieber but it's a no for me! Justin is far too talented for these shenanigans. 'There comes a point where maturity needs to set in. This is honestly embarrassing. Imagine if Hailey posted a video like this. She would be brutally scrutinized.' Others came out in support of Bieber, saying: 'Bro spent his childhood making YALL happy, now he's focused on things that make HIM happy. I'm not mad at that at all. All I see is a free spirit.' 'I see two friends vibin too they're own drum!' Bieber stunned fans on Thursday when he finally released his highly anticipated seventh studio album years after first teasing it. Bieber's new LP Swag dropped at midnight ET/9 p.m. PT following the last-minute launch earlier in the day of billboards around the world and a rush of social media posts. The hitmaker left fans plenty to chew on with newly released songs featuring cryptic lyrics, including Walking Away, which seems to allude to his rumored marriage problems with his wife Hailey, 28. One track, Therapy Session, was nothing but a skit between Bieber and the actor and comedian Druski in which they appeared to defend his mental health and recent bizarre social media meltdowns against fans claiming that 'he's f***in' losin' his mind.' Justin released the album, which features 21 songs, four years after his previous album Justice dropped to mixed reviews but solid sales. Swag features guest vocals from Gunna and Cash Cobain, as well as a particularly raunchy verse from the rapper Sexyy Red that left fans blushing and begging for a sweeter version without her. As Bieber quickly publicized the album, he and his wife Hailey shared numerous moody photographs of the two and their 10-month-old son Jack Blues that appeared to have been shot for the album. The singer launched multiple billboards around the globe on Thursday that appeared to promote the album, with images spotted in New York, Los Angeles, Atlanta and Reykjavík, Iceland. Some of the promotional images included what looked like a track listing for the LP, though it wasn't certain if they reflected the final track order. The apparent song titles for Swag include All I Can Take, Daisies, Yukon, Go Baby, Things You Do, Butterflies, Way It Is, First Place, Soulful, Walking Away, Glory Voice Memo, Devotion, Dadz Love, Therapy Session, Sweet Spot, 405, Swag, Zuma House, Too Long and Forgiveness. One song title that was notably missing from the billboard track listings was number 16, Standing On Business. It's not a full-fledged song, but rather another skit between Bieber and Druski that features audio from a confrontation the singer had with paparazzi last month in which he uttered the viral phrase, 'It's not clocking to you that I'm standing on business, is it?' Justin's song Walking Away featured lyrics that appeared to allude to his marriage to Hailey and their recent highly publicized struggles. 'Days go by so fast, don't wanna spend them with you / So tell me why you're throwing stones at my back / You know I'm defenseless,' he sings in the first verse. 'Girl, we better stop before we say some s*** / We've been testing our patience / I think we better off if we just take a break,' he continues. But the chorus and subsequent verses paint a picture of enduring love despite strife. 'Baby, I ain't walking away / You were my diamond / Gave you a ring / I made you a promise / I told you, "I'd change" / It's just human nature / These growing pains / And baby, I ain't walking away,' Bieber sings in the chorus. One fan wrote on X, 'I want everyone who said Justin and Hailey gonna divorce to listen right here cause he ain't walking away.' The cover featured a stark black background with 'SWAG' written in the center in capital letters 'Justin Love Hailely... liKe that's his TRUE LOVE!!!' another fan gushed in response to the album. One fan was particularly moved by Walking Away and said Hailey was 'Justin Bieber's muse.' Other early listeners singled out the love song Devotion, with one fan saying it 'might be one of Justin's best love songs ever.
Yahoo
26-02-2025
- Business
- Yahoo
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care
Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world's first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care GERMANTOWN, Md. and PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE: SENS) and Ascensia Diabetes Care announce the software integration of SweetSpot™ with the Eversense® 365 Continuous Glucose Monitoring (CGM) System in the U.S. This software integration provides endocrinology practices that partner with SweetSpot the ability to continue to improve patient care by seamlessly and regularly reviewing data from patients using Eversense 365, the world's first and only One Year CGM. SweetSpot combines a centralized software platform for managing diabetes device data with wrap-around clinical support services. SweetSpot's virtual team of Certified Diabetes Care and Education Specialists (CDCES) perform monthly CGM data reviews and coordinate with providers and patients on treatment plan assessment and changes. By developing an integration with Eversense 365, SweetSpot can work alongside practices to act on this unique system's CGM data in between patients' scheduled appointments, allowing for more personalized support. These regular data reviews help ensure patients get timely treatment adjustments, keeping them better connected to their diabetes care team year-round with a goal of improving glycemic control. Practices can also unlock new opportunities through SweetSpot's automated capture of reimbursable care events, making partnering with SweetSpot both clinically impactful and operationally efficient. Eversense 365 is developed by Senseonics and brought to patients by Ascensia Diabetes Care, a subsidiary of PHC Holdings Corporation (TSE: 6523). As the only implantable CGM available, it offers patients a truly differentiated CGM experience, providing One Year of exceptionally accurate monitoring with minimal interruptions. It benefits endocrinologists and care teams by offering their patients confidence in decision-making, long-term peace of mind and enhanced quality of life with just one CGM. The unique approach also allows people to overcome common frustrations and interruptions experienced with traditional, short-term CGMs, so that patients can focus on managing their diabetes and not their CGM. Dr Ralph Oiknine, Physician, Co-Founder and Chief Medical Officer of SweetSpot, said: 'SweetSpot removes all the barriers to implementing a strong, virtual CGM monitoring program for endocrinology practices and all providers involved in diabetes care. Our dedicated team is passionate about transforming how diabetes is managed – and making sure that no opportunities are missed to use the rich data from CGMs for improved care. This integration with Eversense reinforces SweetSpot's commitment to seamless diabetes management, driving better patient outcomes and practice growth for our partners by integrating more CGM options, such as the only implantable CGM on the market.' Mukul Jain, Chief Operating Officer of Senseonics, added: 'We are pleased to enable integration with SweetSpot to help healthcare providers using the software platform to optimize care for patients using Eversense 365. Our CGM offers a completely fresh approach to diabetes management by collecting a whole year of glucose data with just one CGM. We continue to focus on bringing Eversense 365 to more people across the country and are excited to see how integrations like this can further enhance our compelling offering for patients and healthcare providers.' Dr. Jacob Vadakekalam of the Diabetes & Glandular Disease (DGD) Clinic in San Antonio, Texas, added: 'As a doctor committed to providing the best care possible, I am pleased about the partnership between SweetSpot and Eversense. This collaboration represents a step forward in healthcare integration, and I believe it will have a positive impact on diabetes management for my patients here at the Diabetes & Glandular Disease Clinic and in turn minimizing future hospitalizations.' Notes for Editors About Eversense The Eversense® Continuous Glucose Monitoring (CGM) Systems are indicated for continually measuring glucose levels for up to 365 days for Eversense® 365 and 180 days for Eversense® E3 in persons with diabetes age 18 and older. The systems are indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time per week after day 13 for Eversense® 365 and one time per day after day 21 for Eversense® E3, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense CGM Systems are prescription devices; patients should talk to their health care provider to learn more. For important safety information, see A media kit for Eversense 365, including images, logos and further information, can be accessed at About SweetSpot SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care. SweetSpot combines a centralized software platform for managing diabetes device data, such as data from CGMs and insulin pumps, with wrap-around clinical support services. SweetSpot's virtual team of Certified Diabetes Care and Education Specialists (CDCES) perform monthly CGM data reviews and coordinate with providers and patients to facilitate treatment plan changes. By actively managing and remotely reviewing CGM data between patient visits, we ensure patients receive timely treatment adjustments to improve glycemic control and patient outcomes. Additionally, SweetSpot's automated capture of reimbursable care events optimizes CPT code utilization, unlocking new revenue streams for practices and making our partnerships both clinically effective and financially more information, visit About Senseonics Senseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM system Eversense® 365 includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone. About Ascensia Diabetes Care Ascensia Diabetes Care is a global company focused entirely on helping people with diabetes. Our mission is to empower those living with diabetes through innovative solutions that simplify and improve their lives. We are home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® Continuous Glucose Monitoring Systems from Senseonics. These products combine advanced technology with user-friendly functionality to help people with diabetes manage their condition and make a positive difference to their lives. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity. Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation. Ascensia products are sold in more than 100 countries. Ascensia has around 1,400 employees and operations in 29 countries. For further information, please visit the Ascensia Diabetes Care website at: About PHC Holdings Corporation PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Ascensia Diabetes Care Holdings AG, Epredia Holdings Ltd., LSI Medience Corporation, Mediford Corporation, and Wemex. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group's consolidated net sales in FY2023 were JPY 353.9 billion with global distribution of products and services in more than 125 countries. Forward Looking Statements Any statements in this press release about the expectations regarding potential impact on patients' and providers' experience and outcomes, and other statements containing the words "believe," 'expect,' 'intend,' 'may,' 'projects,' 'will,' 'planned,' and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: uncertainties inherent in the new product launch and ongoing commercialization of Eversense 365, uncertainties inherent in the coordination with third parties and new partners, uncertainties in prescriber and patient decisions and responses to new technology or initiatives, and such other factors as are set forth in the risk factors detailed in Senseonics' Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent quarterly reports on Form 10-Q filed with the SEC under the heading "Risk Factors." In addition, the forward-looking statements included in this press release represent Senseonics' views as of the date hereof. Senseonics anticipates that subsequent events and developments will cause Senseonics' views to change. However, while Senseonics may elect to update these forward-looking statements at some point in the future, Senseonics specifically disclaims any obligation to do so except as required by law. These forward-looking statements should not be relied upon as representing Senseonics' views as of any date subsequent to the date hereof. Ascensia Communications Contact: Tim StamperFTI Senseonics Investor Contact Jeremy FefferLifeSci Advisorsinvestors@ SweetSpot Communications Contact: Joelle FredmanDirector of Marketingjfredman@ in to access your portfolio
